Creatine kinase-MB elevation following stent implantation.

[1]  K. Harjai,et al.  Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[2]  A. Jeremias,et al.  Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. , 2004, Journal of the American College of Cardiology.

[3]  J. Killian,et al.  Cardiac rehabilitation after myocardial infarction in the community. , 2004, Journal of the American College of Cardiology.

[4]  J. Ioannidis,et al.  Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. , 2003, Journal of the American College of Cardiology.

[5]  William Wijns,et al.  Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) , 2003, The Lancet.

[6]  S. Silber,et al.  Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions , 2003, Circulation.

[7]  D. Baim,et al.  Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. , 2002, Journal of the American College of Cardiology.

[8]  D. Baim,et al.  Stent Thrombosis in the Modern Era: A Pooled Analysis of Multicenter Coronary Stent Clinical Trials , 2001, Circulation.

[9]  D G Altman,et al.  What do we mean by validating a prognostic model? , 2000, Statistics in medicine.

[10]  R. Califf,et al.  Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial , 1999, The Lancet.